Home / Share Market News / 52-Week Lows / Is opportunity knocking? 2 ASX All Ordinaries shares hitting 52-week lows

Is opportunity knocking? 2 ASX All Ordinaries shares hitting 52-week lows

Catch a falling knife? Or opportunity knocking?

Posted by
Bernd Struben
Bernd Struben earned his BA in economics from the University of Michigan in 1991, with post-graduate studies in environmental economics at the University of Connecticut. Over the years he’s written about and analysed the tourism industry in the Caribbean; Europe’s commercial real estate markets; and, since moving to Australia in 2010, global and Aussie share markets. Bernd studies geopolitical and macroeconomic trends, alongside sector and company specific data, to gauge what he believes could be tomorrow's best investments. In his free time, you might find Bernd at the beach with his family or working on his next science fiction novel.
Published
| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is on a bit of a rollercoaster today.

At time of writing, the index is up 0.6% after almost dipping into the red in the early lunch hour.

This comes after investors, spooked by Russia's invasion of Ukraine, hit the sell button yesterday. That saw the All Ordinaries close for a 2.8% loss for the day.

While the index is clawing back some of its losses, these 2 All Ordinaries shares are heading sharply in the other direction.

Two children sit amid a tangle of wires at a desk looking sad and despondent.

Image source: Getty Images

2 ASX All Ordinaries shares hitting 52-week lows

First up we have Bravura Solutions Ltd (ASX: BVS). The ASX tech shares provides software solutions for the wealth management, life insurance, and funds administration industries.

The Bravura share price is down more than 17% today, sinking it to 52-week lows to $1.56.

This comes on the back of the release of its half year financial results today. While the reporting period saw some strong figures, management downgraded its net profit after tax (NPAT) guidance for the full 2022 financial year.

With the Bravura share price now down 47% in 12 months, is opportunity knocking on this beaten down All Ordinaries share?

According to Goldman Sachs it may well be. The broker has a buy rating on the stock, with its most recent price target (issued 24 November 2021) for Bravura of $3.70 per share. That's 137% above the current price.

Also hitting 52-week lows

Our second ASX All Ordinaries share hitting 52-week lows today is healthcare services provider, Integral Diagnostics Ltd (ASX: IDX).

The Integral Diagnostics share price is down 12% today to $3.45 per share. That brings its 12 months losses to 29%.

This comes after the company emerged from a 2-day trading halt today and following the release of its half year results yesterday, along with the announcement that it had agreed to acquire Peloton Radiology. While the results were solid, the company's dividend payout slipped.

Catch a falling knife? Or opportunity knocking?

According to Goldman Sachs, this All Ordinaries share also could be an opportunity.

Yesterday the broker had a buy rating on Integral Diagnostics, with a price target of $5. That's 45% above the current share price.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Bravura Solutions Ltd. The Motley Fool Australia owns and has recommended Bravura Solutions Ltd. The Motley Fool Australia has recommended Integral Diagnostics Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on 52-Week Lows

A disappointed man slumps in his chair and holds his head while playing an online game.
52-Week Lows

These 4 ASX 200 shares have slumped to fresh 52-week lows: Buy, sell or hold?

| Samantha Menzies

Should investors buy in the dip or sit on the sidelines?

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

| Aaron Teboneras

Is this drop a warning sign?

Read more »

a woman sits next to her computer screen with her head in her hands with the screens slowing graphs on downward trajectories.
52-Week Lows

Can the beaten-down CSL share price ever reach $300 again?

| Aaron Teboneras

CSL is near decade lows. Can it ever climb back?

Read more »

A stressed businessman sits next to his briefcase with his head in his hands, while the ASX boards behind him show shares crashing.
52-Week Lows

CSL's collapse deepens. Why this ASX giant can't find a floor

| Aaron Teboneras

CSL shares hit a 9-year low as new demand concerns emerge.

Read more »

Unsure man analysing data on laptop.
52-Week Lows

Down 50% in the past year, are these ASX 200 shares too cheap to ignore?

| Aaron Bell

These stocks have recently recovered from yearly lows.

Read more »

Lines of codes and graphs in the background with woman looking at laptop trying to understand the data.
52-Week Lows

These 3 ASX 200 stocks hit a 52-week low: Buy, sell or hold?

| Samantha Menzies

These shares have all tumbled in value this year.

Read more »

Person with thumbs down and a red sad face poster covering their face.
52-Week Lows

Harvey Norman just hit a 52-week low. Is this beaten-down ASX retailer becoming too cheap to ignore?

| Aaron Teboneras

Harvey Norman sinks to 52-week low as sentiment weakens further.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
52-Week Lows

Down 43% this year, this ASX tech stock is now back at January 2025 levels

| Aaron Teboneras

Megaport shares are down 43% this year as weak momentum continues.

Read more »